TP53 and cancer: In contrast, knockdown of p53 using two independent siRNAs significantly reduced the expression of circASCC3 and ASCC3 in cancer cells when treated with Cisplatin or Nutlin-3 (Fig. 2 E–G and SI Appendix, Fig. S2 B–D).